Loading...
AVNT logo

Avient CorporationNYSE:AVNT Aktierapport

Marknadsvärde US$3.4b
Aktiekurs
US$36.76
US$48.57
24.3% undervärderad intrinsisk rabatt
1Y7.5%
7D-2.1%
Portföljens värde
Utsikt

Avient Corporation

NYSE:AVNT Aktierapport

Börsvärde: US$3.4b

AVNT Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Community Contributor
CA$5.07FV 68.0% undervärderad intrinsisk rabatt
4849.4%Revenue growth p.a.
13.3k
37
1
271
2mo ago

Avient Corporation Konkurrenter

Prishistorik och prestanda

Sammanfattning av aktiekursernas upp- och nedgångar samt förändringar för Avient
Historiska aktiekurser
Aktuell aktiekursUS$36.76
52 veckors högstaUS$44.85
52 veckors lägstaUS$27.48
Beta1.41
1 månads förändring0.99%
3 månaders förändring1.69%
1 års förändring7.49%
3 års förändring-4.49%
5 års förändring-31.60%
Förändring sedan börsintroduktionen292.11%

Senaste nyheter och uppdateringar

Recent updates

AVNT: Future Crude Linked Cost Controls Will Support ReRating Potential

Analysts have maintained Avient’s fair value estimate at $48.57 while refining assumptions, including a slightly lower discount rate. This reflects recent price target increases from several firms, alongside a more cautious sector stance from others.

AVNT: Future Crude Linked Cost Management Will Drive ReRating Potential

Analysts have modestly adjusted their price target on Avient to $48.57, with updated assumptions reflecting a slightly lower discount rate and broadly unchanged expectations for revenue growth, profit margins, and future P/E. Recent Street research cites higher crude linked input costs and mixed sector views, alongside higher individual firm targets up to $52.

AVNT: Future Commodity Cost Management Will Drive ReRating Potential

Narrative Update The updated analyst price target for Avient edges lower by about $1, reflecting slightly higher discount rate assumptions and cautious views on raw material cost pressures. This comes even as several firms have recently lifted their individual targets following earnings and valuation roll-­forwards.

AVNT: Future End Market Recovery And Higher P/E Are Expected To ReRate Shares

Narrative Update on Avient Our analyst price target for Avient edges up from $48.25 to $49.50 as analysts cite updated valuation work, including higher forward price targets and refined expectations for revenue growth, profit margins and future P/E multiples following recent sector and company specific research. Analyst Commentary Recent research on Avient shows a mix of optimism about the longer term setup and caution around near term input cost and industry headwinds.

AVNT: Demand Recovery In Key End Markets Will Drive Future Multiple

The analyst fair value estimate for Avient has moved from $41.75 to $48.25, reflecting higher Street price targets as analysts update their models and adjust assumptions around future revenue growth, profit margins, and P/E multiples. Analyst Commentary Street research on Avient over the past few months has centered on revised valuation frameworks, longer dated earnings assumptions, and how quickly demand in key end markets might stabilize.

There May Be Reason For Hope In Avient's (NYSE:AVNT) Disappointing Earnings

Feb 19
There May Be Reason For Hope In Avient's (NYSE:AVNT) Disappointing Earnings

Avient: Becoming A Better Business

Feb 18

Defense And Healthcare Materials Will Drive A Stronger Long Term Outlook

Catalysts About Avient Avient supplies specialized materials and color and additive solutions for end markets such as health care, defense, telecommunications, packaging and transportation. What are the underlying business or industry changes driving this perspective?

AVNT: Fair View Suggests Demand Recovery And Margins Will Drive Future Multiple

Narrative Update on Avient The analyst price target for Avient has been updated to US$41.75, a US$4.75 increase from the prior US$37 level. This change reflects a combination of higher targets from some firms and lower targets from others, as well as modest adjustments to assumptions for discount rate, revenue growth, profit margin and future P/E.

AVNT: Fair View Suggests Execution Will Shape Future Multiple Potential

Narrative Update on Avient The analyst price target for Avient has been adjusted slightly higher from $41.00 to $41.75, reflecting analysts’ updated views on earnings quality and valuation following recent target changes across the Street. Analyst Commentary Recent research updates on Avient present a mixed picture, with some analysts lifting targets and others trimming them, reflecting different views on how the company might execute in a challenging industry setup.

AVNT: Reset Price View Will Support Future Multiple Expansion

Narrative Update Overview Analysts have trimmed their price target on Avient to US$36 from US$42, reflecting updated views on the shares while maintaining broadly consistent assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary on Avient centers on the reset in the price target to US$36.

AVNT: Dividend And Buyback Execution Will Support Future Multiple Expansion

Avient's analyst price target has been reduced by $6 to $36, as analysts factor in more conservative expectations for the shares while maintaining a positive long term outlook. Analyst Commentary Analysts are recalibrating their expectations for Avient, balancing a still constructive long term view on execution and earnings power with a more tempered near term valuation framework.

AVNT: New Leadership Will Drive 4% Organic Expansion As Cyclical Headwinds Ease

Avient's updated analyst price target has edged lower, reflecting a recalibration toward the mid 30 dollar to high 40 dollar range as analysts balance near term macro and cyclical pressures against improving margin prospects and the potential for faster organic growth under the new strategic focus. Analyst Commentary Recent Street research reflects a balanced mix of optimism around Avient's strategic pivot and caution on near term earnings power, resulting in a wide but grounded valuation range.

AVNT: Renewed Leadership Will Drive Recovery With 4% Organic Expansion Ahead

Analysts have trimmed their price target for Avient by $1.13 to $41.00. This reflects cautious sentiment following reduced profit margin forecasts and recent reassessments of growth potential.

AVNT: Renewed Leadership Will Drive Recovery In High-Growth End Markets

Analysts have modestly reduced their fair value estimate for Avient from $43.25 to $42.13. They cite a more conservative revenue growth outlook, even though profit margins and long-term growth opportunities continue to be supported by recent positive coverage and management strategy shifts.

Avient (NYSE:AVNT) Will Pay A Larger Dividend Than Last Year At $0.275

Nov 05
Avient (NYSE:AVNT) Will Pay A Larger Dividend Than Last Year At $0.275

Avient (NYSE:AVNT) Is Increasing Its Dividend To $0.275

Oct 12
Avient (NYSE:AVNT) Is Increasing Its Dividend To $0.275

High-Performance Healthcare Materials And Sustainable Polymers Will Create Value

Analysts have raised Avient’s price target to $43.25, citing increased confidence in the new CEO’s strategic focus on high-growth markets, anticipated organic growth, and recovery potential in cyclical end markets. Analyst Commentary Increased optimism due to the new CEO's strategic focus on high-growth platforms and markets.

Avient Corporation's (NYSE:AVNT) Earnings Haven't Escaped The Attention Of Investors

Sep 13
Avient Corporation's (NYSE:AVNT) Earnings Haven't Escaped The Attention Of Investors

Are Investors Undervaluing Avient Corporation (NYSE:AVNT) By 30%?

Jul 14
Are Investors Undervaluing Avient Corporation (NYSE:AVNT) By 30%?

Is Avient Corporation (NYSE:AVNT) Potentially Undervalued?

May 23
Is Avient Corporation (NYSE:AVNT) Potentially Undervalued?

Is Avient (NYSE:AVNT) A Risky Investment?

May 08
Is Avient (NYSE:AVNT) A Risky Investment?

Is There An Opportunity With Avient Corporation's (NYSE:AVNT) 49% Undervaluation?

Apr 07
Is There An Opportunity With Avient Corporation's (NYSE:AVNT) 49% Undervaluation?

Some Confidence Is Lacking In Avient Corporation's (NYSE:AVNT) P/E

Mar 23
Some Confidence Is Lacking In Avient Corporation's (NYSE:AVNT) P/E

Avient: Specialty Play Slowly Becomes More Special

Mar 22

At US$44.21, Is Avient Corporation (NYSE:AVNT) Worth Looking At Closely?

Feb 19
At US$44.21, Is Avient Corporation (NYSE:AVNT) Worth Looking At Closely?

Does Avient (NYSE:AVNT) Have A Healthy Balance Sheet?

Jan 20
Does Avient (NYSE:AVNT) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Avient Corporation (NYSE:AVNT) Suggests It's 31% Undervalued

Jan 03
An Intrinsic Calculation For Avient Corporation (NYSE:AVNT) Suggests It's 31% Undervalued

Earnings Tell The Story For Avient Corporation (NYSE:AVNT)

Dec 18
Earnings Tell The Story For Avient Corporation (NYSE:AVNT)

Is It Time To Consider Buying Avient Corporation (NYSE:AVNT)?

Nov 18
Is It Time To Consider Buying Avient Corporation (NYSE:AVNT)?

Avient: Specialization Strategy Is Growing Margins And Driving The Bottom-Line Growth

Nov 13

Avient's (NYSE:AVNT) Dividend Will Be Increased To $0.27

Nov 02
Avient's (NYSE:AVNT) Dividend Will Be Increased To $0.27

Avient (NYSE:AVNT) Seems To Use Debt Quite Sensibly

Sep 26
Avient (NYSE:AVNT) Seems To Use Debt Quite Sensibly
User avatar

Navigating Challenges, The Company Leverages Healthcare Innovations And Tactical Partnerships For Growth

Avient's strategy focuses on market share gain in varied sectors, especially healthcare, promising revenue growth with innovations like drug delivery devices.

A Look At The Intrinsic Value Of Avient Corporation (NYSE:AVNT)

Aug 03
A Look At The Intrinsic Value Of Avient Corporation (NYSE:AVNT)

Why Avient Corporation (NYSE:AVNT) Could Be Worth Watching

Jul 02
Why Avient Corporation (NYSE:AVNT) Could Be Worth Watching

With Avient Corporation (NYSE:AVNT) It Looks Like You'll Get What You Pay For

Jun 14
With Avient Corporation (NYSE:AVNT) It Looks Like You'll Get What You Pay For

Aktieägarnas avkastning

AVNTUS ChemicalsUS Marknad
7D-2.1%-0.4%0.8%
1Y7.5%11.6%27.7%

Avkastning vs industri: AVNT presterade sämre än US Chemicals branschen som gav 11.6 % under det senaste året.

Avkastning vs Marknaden: AVNT presterade sämre än US marknaden som gav 27.7 % under det senaste året.

Prisvolatilitet

Is AVNT's price volatile compared to industry and market?
AVNT volatility
AVNT Average Weekly Movement5.0%
Chemicals Industry Average Movement7.6%
Market Average Movement7.2%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market3.3%

Stabil aktiekurs: AVNT har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.

Volatilitet över tid: AVNT s veckovolatilitet ( 5% ) har varit stabil under det senaste året.

Om företaget

GrundadAnställdaVD OCH KONCERNCHEFWebbplats
18859,000Ashish Khandpurwww.avient.com

Avient Corporation är verksamt inom formulering av materiallösningar i USA, Kanada, Mexiko, Europa, Sydamerika och Asien. Företaget är verksamt inom två segment: Color, Additives and Inks och Specialty Engineered Materials. Segmentet Color, Additives and Inks erbjuder kundanpassade färg- och tillsatsmedelskoncentrat i fast och flytande form för termoplaster, dispersioner för härdplaster och specialbläck, kundanpassade flytande system för t.ex. polyester, vinyl, naturgummi och latex, polyuretan och silikon samt egenutvecklade bläck.

Avient Corporation Sammanfattning av grunderna

Hur förhåller sig Avient:s resultat och omsättning till dess börsvärde?
AVNT grundläggande statistik
BörsvärdeUS$3.40b
Vinst(TTM)US$81.90m
Intäkter(TTM)US$3.26b
41.2x
P/E-förhållande
1.0x
P/S-förhållande

Resultat & intäkter

Viktig lönsamhetsstatistik från den senaste resultatrapporten (TTM)
AVNT resultaträkning (TTM)
IntäkterUS$3.26b
Kostnad för intäkterUS$2.20b
BruttovinstUS$1.06b
Övriga kostnaderUS$976.30m
IntäkterUS$81.90m

Senast redovisade vinst

Dec 31, 2025

Nästa vinstdatum

May 07, 2026

Vinst per aktie (EPS)0.89
Bruttomarginal32.46%
Nettovinstmarginal2.51%
Skuld/egenkapitalförhållande80.6%

Hur har AVNT utvecklats på lång sikt?

Se historisk utveckling och jämförelse

Utdelningar

3.0%
Aktuell utdelningsavkastning
121%
Utbetalningskvot

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/05/01 04:22
Aktiekurs vid dagens slut2026/05/01 00:00
Intäkter2025/12/31
Årlig intjäning2025/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Avient Corporation bevakas av 18 analytiker. 8 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Ghansham PanjabiBaird
Prashant JuvekarCitigroup Inc
David BegleiterDeutsche Bank